Abstract
Background: Solid tumors are acidic due to the combination of high rates of glycolysis with poor perfusion. The consequent establishment of the acidosis state leads to an immunosuppressive mechanism in the tumor microenvironment, inhibiting T-cell activation and leading to tumor growth. We previously showed that neutralization of tumor acidity using sodium bicarbonate could be additive or synergistic with checkpoint blockade (anti-PD1 and anti-CTLA4) in pre-clinical models. However, the buffer therapy phase I/IIa clinical trials failed due to poor patient compliance.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have